MD, PhDBordeaux PharmacoEpi Bordeaux, Gironde, France
Biogen (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)
OP-1D - Risk of Malignancies in Newly Treated Patients with Disease-modifying Drugs for Multiple Sclerosis: Assessment According to Cohort and Nested-case Control Approaches
Wednesday, August 25, 20214:30 PM – 6:00 PM US Eastern Time